Eilika Weber-Ban Lab (@ewb_lab) 's Twitter Profile
Eilika Weber-Ban Lab

@ewb_lab

We study #proteostasis and cellular degradation machines in #mycobacteria. #proteasome #pupylation bsky.app/profile/ewb-la…

ID: 1047807847738888192

linkhttp://www.weber-ban-lab.ethz.ch calendar_today04-10-2018 11:17:13

451 Tweet

956 Followers

203 Following

Eilika Weber-Ban Lab (@ewb_lab) 's Twitter Profile Photo

Looking forward to Rudi Glockshuber's Farewell Symposium! Great science and a chance to get together, say goodbye and give thanks! 📅 Friday, November 22nd 📍 ETH Zurich, Hönggerberg Campus We look forward to seeing you there! Glockshuber group ETH Zurich

Looking forward to Rudi Glockshuber's Farewell Symposium! Great science and a chance to get together, say goodbye and give thanks! 
📅 Friday, November 22nd  
📍 ETH Zurich, Hönggerberg Campus  

We look forward to seeing you there!
<a href="/Glockshuber_lab/">Glockshuber group</a> <a href="/ETH_en/">ETH Zurich</a>
Ivan Ahel Lab (@ivanahellab) 's Twitter Profile Photo

Our laboratory is looking for a postdoc with expertise in protein biochemistry and structural biology to work on novel pathways regulated by ADP-ribosylation of nucleic acids. Please RT.

EMBO Events (@emboevents) 's Twitter Profile Photo

Registration is now open for EMBO Workshop on Protein quality control: From molecular mechanisms to aging and disease 18 – 23 May 2025 in Hersonissos, Greece 📜 Early bird registration deadline: 31 Jan 2025 meetings.embo.org/event/25-prote… #EMBOproteinQualityControl

Jacob Corn (@jcornlab) 's Twitter Profile Photo

Cells are filled with toxic stuff that damages healthy proteins. Is that garbage just left to rot on the curb? No way! Ubiquitin ligases have evolved to recognize chemical damage and clean it up! nature.com/articles/s4158…

Science Magazine (@sciencemagazine) 's Twitter Profile Photo

An oral tablet vaccine for norovirus based on an adenoviral-vectored vaccine that delivers VP1 is safe in older adults and produces a notable antibody response in the mucosa that persists for 210 days, according to results from a phase 1 trial. Learn more in Science Translational Medicine:

An oral tablet vaccine for norovirus based on an adenoviral-vectored vaccine that delivers VP1 is safe in older adults and produces a notable antibody response in the mucosa that persists for 210 days, according to results from a phase 1 trial. 

Learn more in <a href="/ScienceTM/">Science Translational Medicine</a>:
Eilika Weber-Ban Lab (@ewb_lab) 's Twitter Profile Photo

Check out our new study revealing how ATP-independent activator Bpa binds asymmetrically to the Mtb #proteasome — and pinpointing key Bpa residues involved in substrate interaction. 👏 Tatjana v. Rosen Rafał Zdanowicz @yasserelhadeg 🔗nature.com/articles/s4146…